Skip to main navigation
Skip to search
Skip to main content
Fujita Health University Home
English
日本語
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Efficacy and safety of panitumumab for K-ras wild-type unresectable or recurrent colorectal cancer - A study focusing on first-line treatment
Shingo Mitomo
, Takayuki Suto
, Akira Umemura
, Kaoru Ishida
, Kiminori Kanno
, Daiki Takeda
, Tomonori Fujita
, Koki Otsuka
, Hiroyuki Nitta
, Noriyuki Uesugi
, Tamotsu Sugai
, Go Wakabayashi
Research output
:
Contribution to journal
›
Article
›
peer-review
1
Citation (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Efficacy and safety of panitumumab for K-ras wild-type unresectable or recurrent colorectal cancer - A study focusing on first-line treatment'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Colorectal Cancer
100%
Ras Signaling
100%
Panitumumab
100%
Adverse Event
37%
Peripheral Neuropathy
25%
Neutropenia
25%
Neoplasm
12%
Surgery
12%
Combination Therapy
12%
Idiopathic Interstitial Pneumonia
12%
Dermatosis
12%
Chemotherapy Agent
12%
Pharmacology, Toxicology and Pharmaceutical Science
Colorectal Cancer
100%
Panitumumab
100%
Adverse Event
37%
Neutropenia
25%
Peripheral Neuropathy
25%
Neoplasm
12%
Combination Therapy
12%
Interstitial Pneumonia
12%
Skin Disease
12%
Chemotherapy Agent
12%
Keyphrases
Single-agent Chemotherapy
12%